These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 27007612

  • 21. High frequency of calcinosis in juvenile dermatomyositis: a risk factor study.
    Clemente G, Piotto DG, Barbosa C, Peracchi OA, Len CA, Hilário MO, Terreri MT.
    Rev Bras Reumatol; 2012 Aug; 52(4):549-53. PubMed ID: 22885422
    [Abstract] [Full Text] [Related]

  • 22. Race, Income, and Disease Outcomes in Juvenile Dermatomyositis.
    Phillippi K, Hoeltzel M, Byun Robinson A, Kim S, Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry Investigators.
    J Pediatr; 2017 May; 184():38-44.e1. PubMed ID: 28410093
    [Abstract] [Full Text] [Related]

  • 23. Complete and sustained resolution of calcinosis universalis in a juvenile dermatomyositis case with mycophenolate mofetil.
    Çakan M, Karadağ ŞG, Ayaz NA.
    Turk J Pediatr; 2019 May; 61(5):771-775. PubMed ID: 32105011
    [Abstract] [Full Text] [Related]

  • 24. New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment.
    Mukamel M, Horev G, Mimouni M.
    J Pediatr; 2001 May; 138(5):763-6. PubMed ID: 11343059
    [Abstract] [Full Text] [Related]

  • 25. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis.
    Fisler RE, Liang MG, Fuhlbrigge RC, Yalcindag A, Sundel RP.
    J Am Acad Dermatol; 2002 Oct; 47(4):505-11. PubMed ID: 12271292
    [Abstract] [Full Text] [Related]

  • 26. Comparison of clinical and laboratory features and treatment responses in patients with clinically amyopathic juvenile dermatomyositis and classical juvenile dermatomyositis.
    Gezgin Yıldırım D, Baglan E, Güngörer V, Yıldız C, Tuncez S, Bülbül M, Acar B, Bakkaloğlu SA.
    Int J Rheum Dis; 2023 Aug; 26(8):1504-1511. PubMed ID: 37288472
    [Abstract] [Full Text] [Related]

  • 27. Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry.
    Carriquí-Arenas S, Mosquera JM, Quesada-Masachs E, López M, Clemente D, Boteanu A, Udaondo C, de Inocencio J, Nieto JC, Riancho L, Núñez E, Sánchez-Manubens J, Lirola MJ, Roldán R, Camacho M, Martínez M, Medrano M, Alcañiz P, Antón J, Iglesias E.
    Pediatr Rheumatol Online J; 2024 Jul 22; 22(1):66. PubMed ID: 39039532
    [Abstract] [Full Text] [Related]

  • 28. Juvenile dermatomyositis in Thai children: Retrospective review of 30 cases from a tertiary care center.
    Nitiyarom R, Charuvanij S, Likasitwattanakul S, Thanoophunchai C, Wisuthsarewong W.
    Indian J Dermatol Venereol Leprol; 2022 Jul 22; 88(2):162-170. PubMed ID: 34491668
    [Abstract] [Full Text] [Related]

  • 29. Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset.
    Sanner H, Gran JT, Sjaastad I, Flatø B.
    Rheumatology (Oxford); 2009 Dec 22; 48(12):1541-7. PubMed ID: 19776224
    [Abstract] [Full Text] [Related]

  • 30. Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis.
    Orandi AB, Dharnidharka VR, Al-Hammadi N, Baszis KW, CARRA Legacy Registry Investigators.
    Pediatr Rheumatol Online J; 2018 Dec 29; 16(1):84. PubMed ID: 30594206
    [Abstract] [Full Text] [Related]

  • 31. Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients.
    Mathiesen PR, Zak M, Herlin T, Nielsen SM.
    Clin Exp Rheumatol; 2010 Dec 29; 28(5):782-9. PubMed ID: 21029565
    [Abstract] [Full Text] [Related]

  • 32. Is Anti-NXP2 Autoantibody a Risk Factor for Calcinosis and Poor Outcome in Juvenile Dermatomyositis Patients? Case Series.
    Toplak N, Pimpale Chavan P, Rosina S, Dallos T, Rotem Semo O, Aguiar CL, Khubchandani R, Ravelli A, Patwardhan A.
    Front Pediatr; 2021 Dec 29; 9():810785. PubMed ID: 35280444
    [Abstract] [Full Text] [Related]

  • 33. Cardiac findings in children with juvenile Dermatomyositis at disease presentation.
    Cantez S, Gross GJ, MacLusky I, Feldman BM.
    Pediatr Rheumatol Online J; 2017 Jul 11; 15(1):54. PubMed ID: 28693511
    [Abstract] [Full Text] [Related]

  • 34. The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.
    Hoeltzel MF, Oberle EJ, Robinson AB, Agarwal A, Rider LG.
    Curr Rheumatol Rep; 2014 Dec 11; 16(12):467. PubMed ID: 25366934
    [Abstract] [Full Text] [Related]

  • 35. [Juvenile amyopathic dermatomyositis and calcinosis].
    Escorial Briso-Montiano M, Solís Sánchez P, Baeza Velasco M, Alonso Rubio A, de Gregorio Alvarez Z.
    An Pediatr (Barc); 2005 Mar 11; 62(3):286-8. PubMed ID: 15737292
    [Abstract] [Full Text] [Related]

  • 36. Recovery of Severe Muscular and Fascial Calcinosis After Treatment With Bisphosphonates in a Child With Juvenile Dermatomyositis.
    Cañas CA, Bonilla-Abadía F, Mejía M, Tobón GJ.
    J Clin Rheumatol; 2015 Aug 11; 21(5):267-9. PubMed ID: 26203832
    [Abstract] [Full Text] [Related]

  • 37. Local injection of infliximab into calcinosis lesions in patients with juvenile dermatomyositis (JDM): a clinical trial.
    Shiari R, Khalili M, Zeinali V, Shashaani N, Samami M, Moghaddamemami FH.
    Pediatr Rheumatol Online J; 2024 Jan 02; 22(1):2. PubMed ID: 38166943
    [Abstract] [Full Text] [Related]

  • 38. Characterization of the biomarkers related to the clinical course and outcomes of juvenile dermatomyositis.
    Lin TW, Hu YC, Chiang BL.
    J Microbiol Immunol Infect; 2023 Apr 02; 56(2):416-423. PubMed ID: 36572597
    [Abstract] [Full Text] [Related]

  • 39. Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis.
    Riley P, McCann LJ, Maillard SM, Woo P, Murray KJ, Pilkington CA.
    Rheumatology (Oxford); 2008 Jun 02; 47(6):877-80. PubMed ID: 18403404
    [Abstract] [Full Text] [Related]

  • 40. Characteristics of juvenile dermatomyositis in Japan.
    Kobayashi S, Higuchi K, Tamaki H, Wada Y, Wada N, Kubo M, Koike Y, Nagata M, Tatsuzawa O, Fujikawa S.
    Acta Paediatr Jpn; 1997 Apr 02; 39(2):257-62. PubMed ID: 9141268
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.